Ledger.Open graph →
SEC Form D · filed March 6, 2018

Sun BioPharma, Inc

Offering
$20.0M
Sold
$840K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WACONIA, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Bridget Martin · Rochester, NYDirectorMatthew Nyren · New York, NYDirectorColin Mackay · GEORGE TOWN, Grand Cayman, Cayman IslandsDirectorSarah Blankinship · Seattle, WAExec · DirectorD. R. Schemel · WACONIA, MNDirectorPaul W. Schaffer · WACONIA, MNDirectorDavid B. Kaysen · WACONIA, MNExec · DirectorSuzanne T. Gagnon · WACONIA, MNDirectorJ. R. Paulson, Jr · WACONIA, MNDirectorPaul Adams · Rochester, NYDirectorGregory Kris · Chicago, ILDirectorDavid Bree · Grand Cayman, Cayman IslandsDirectorJohn W. Rosenthal · Mishawaka, INExecMichael T. Cullen · WACONIA, MNExec · DirectorJan E. Frogg · Grand Cayman, Cayman IslandsDirectorDalvir S. Gill · WACONIA, MNDirectorMonroe Capital, Inc · Rochester, NYExec · DirectorLauren Mulholland · Lexington, KYDirectorThomas P. Hoban, Jr · Everett, WAExecJonathan Roney · GEORGE TOWN, Grand Cayman, Cayman IslandsDirectorJeffrey S. Mathiesen · WACONIA, MNDirectorShawn A. Hoban · Everett, WADirectorScott R. Kellen · WACONIA, MNExecMichael Wasser · Seattle, WADirectorMark E. Stabile · Grand Cayman, Cayman IslandsExec · DirectorMichael A. Harmon · Everett, WAExec · DirectorCarl Y. Baggett · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗